Nova Biomedical is a company dedicated to using advanced technology to develop better blood testing analyzers for medical use. These products are called in vitro diagnostic devices (IVD). We use some of the same advanced technology to provide the biotechnology industry with innovative instruments for cell culture monitoring. Nova is the largest privately owned IVD company in the U.S. and the third largest in the world, with over 1,200 employees globally. Our eight percent compounded annual growth over nearly a decade is more than double the IVD market growth, making Nova one the fastest growing IVD companies in the world. Corporate Commitment to Quality Nova’s size and rapid growth are the result of customers throughout the world responding to the exceptional quality and value of Nova’s technology, products, and customer service. Our strong corporate commitment to these three areas has made Nova a world leader in clinical, veterinary, and biotechnology chemistry testing analyzers. A Leader in Medical Science Technology Maintaining leadership in any technology industry requires a long-term perspective and commitment to research and development. Nova Biomedical has consistently invested more than 10 percent of sales into research and development — more than double the industry average. Our investment in research and development provides a continuous product pipeline of new and better technology products for our customers. Working at Nova Biomedical We practice our core values of mutual respect, honesty, and integrity throughout Nova. With a strong sense of family in the workplace, we are proud that one third of all our employees have been with us for over 10 years.